BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.4322
+0.0024 (0.56%)
At close: May 12, 2025, 4:00 PM
0.4500
+0.0178 (4.12%)
After-hours: May 12, 2025, 7:51 PM EDT
BioAtla Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for BioAtla stock has a target of 1.00, which predicts an increase of 131.37% from the current stock price of 0.43.
Analyst Consensus: Buy
* Price targets were last updated on Mar 31, 2025.
Analyst Ratings
The average analyst rating for BioAtla stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citizens Capital Markets | Citizens Capital Markets | Buy Maintains $5 → $1 | Buy | Maintains | $5 → $1 | +131.37% | Mar 31, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 31, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 13, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $5 | Buy | Reiterates | $5 | +1,056.87% | Sep 16, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $12 → $5 | Buy | Maintains | $12 → $5 | +1,056.87% | May 23, 2024 |
Financial Forecast
Revenue This Year
n/a
from 11.00M
Revenue Next Year
n/a
EPS This Year
-1.28
from -1.44
EPS Next Year
-1.27
from -1.28
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | 15.5M | ||
| Avg | n/a | n/a | 7.6M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.83 | -0.85 | -1.12 | ||
| Avg | -1.28 | -1.27 | -1.19 | ||
| Low | -1.64 | -1.54 | -1.23 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.